BridgeMD
Tests treatment safety and results for Advanced Digestive Cancer
Official title Identification of Innovative Biomarkers Related to the Immune System or Tumor Microenvironment to Promote the Efficacy of Immunotherapies
ClinicalTrials.gov ID: NCT06626269
What this study is testing
- What it's testing
- The immune system may be involved in the recognition and destruction of tumor cells or cells undergoing transformation. It is also currently accepted that the quality of immune responses can influence the evolution of cancers after chemotherapy.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- General
- Patients ≥ 18 years old
- more than 6 months of life expectancy as assessed by the investigator
- Performance status ECOG 0 ; 1 or 2
- Patient affiliated to or beneficiary of French social security system
You likely can't join if
- General exclusion criteria:
- Patient under guardianship, curatorship or under the protection of justice
- Patient with any medical or psychiatric condition or disease, which would make the patient inappropriate for entry into this study
- Patient unlikely to cooperate with the study and/or poor cooperation anticipated by the investigator
- Patient without health insurance
- Pregnant women
See the full eligibility criteria
- General
- Patients ≥ 18 years old
- more than 6 months of life expectancy as assessed by the investigator
- Performance status ECOG 0 ; 1 or 2
- Patient affiliated to or beneficiary of French social security system
- Informed consent of the subject to participate in the study Specific eligibility criteria: \- Cohort A [Patients with advanced digestive or gynecological cancers eligible to immunotherapies]: Patients with locally...
- General exclusion criteria:
- Patient under guardianship, curatorship or under the protection of justice
- Patient with any medical or psychiatric condition or disease, which would make the patient inappropriate for entry into this study
- Patient unlikely to cooperate with the study and/or poor cooperation anticipated by the investigator
- Patient without health insurance
- Pregnant women
- Subject within the exclusion period of another study or planned by the national volunteer file
The study team makes the final eligibility decision.
Where it's taking place
- Besançon, France
- Dijon, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Besançon, France; Dijon, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.